Nasdaq: GLUE
Monte Rosa Therapeutics insiders
The officers, directors and 10% owners of Monte Rosa Therapeutics, Inc. who hold the most stock, valued at the live GLUE price.
$8.91
GLUE today −$160K (−1.76%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their GLUE stock
- $111M
- Market value
- $761M
- Held by ranked insiders
- 14.6%
Insiders by value of GLUE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Versant Ventures VI GP, L.P. | 10% owner | 6,231,902 | $55.5M | 7.29% | Corporate |
| 2 | Versant Venture Capital VI, L.P. | 10% owner | 5,652,922 | $50.4M | 6.62% | Corporate |
| 3 | Markus Warmuth | President & CEO | 585,038 | $5.2M | 0.68% | 14051st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Monte Rosa Therapeutics; see each profile for the filing.